FDA OKs InfraScan's next-gen device to detect brain bleeding

01/22/2013 | MassDevice.com (Boston)

The FDA has granted InfraScan approval for a next-generation version of its Infrascanner, which employs near-infrared technology to allow for the noninvasive detection of bleeding in the brain. The newly approved device, called the Infrascanner Model 2000, was created in collaboration with the U.S. Marine Corps and Navy and has military specifications, but it could also have applications in sports medicine and other fields.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX